Malaria and the immune system in humans

Chemical Immunology

Volumn 80, Issue , 2002, Pages 229-242

  Perlmann, Peter ^a   Troye Blomberg, Marita ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NITRIC OXIDE; PARASITE ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ANTIBODY PRODUCTION; ANTIGENIC VARIATION; CELL ADHESION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMORAL IMMUNITY; IMMUNE SYSTEM; MALARIA; PARASITE DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0036096650     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058846     Document Type: Review

References (110)

1. Malaria - A neglected disease?
2. The Dielmo project: A longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal
3. Acquired immunity to asexual blood stages
4. Toll-like receptors in the induction of the innate immune response
5. Gamma-globulin and acquired immunity to human malaria
6. 'Natural' T cells responsive to malaria: Evidence implicating immunological cross-reactivity in the maintenance of TCRαβ+ malaria-specific responses from non-exposed donors
7. Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: Stimulation by cytokines and inhibition by neomycin
8. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection
9. Mouse NK1 + T cells
10. Liver CD4- CD8-NK1.1 + TCRαβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro
11. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
12. The CD1 system: Antigen presenting molecules for T cell recognition of lipids and glycolipids
13. Role of γδ T lymphocytes in immune responses in humans and mice
14. Inhibition of Plasmodium falciparum in vitro by human γδ T cells
15. Human γδ T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules
16. γδ cells: A right time and a right place for a conserved third way of protection
17. Activation of NK cells and T cells by NK G2D receptor for stress inducible MICA
18. Treatment of East African Plasmodium falciparum malaria with West African human gammaglobulin
19. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria
20. Antigenic variation in Plasmodium falciparum: Mechanisms and consequences
21. Wild isolates of Plasmodium falciparum malaria show decreased sensitivity to in vitro inhibition of parasite growth mediated by autologous host antibodies
22. Plasmodium falciparum: Selection of parasite subpopulations with decreased sensitivity for antibody-mediated growth inhibition in vitro
23. Cloning the P.falciparum gene encoding PfEMP1, a malaria variant antigen and adherence receptor on the surface of parasitized human erythrocytes
24. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes
25. Two approximately 300 kilodalton Plasmodium falciparum proteins at the surface membrane of infected erythrocytes
26. Cytoadherence by Plasmodium falciparum infected erythrocytes is correlated with the expression of a family of variable proteins in infected erythrocytes
27. Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum
28. Developmental selection of var gene expression in Plasmodium falciparum
29. Antigenic variation in malaria: In situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum
30. stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens
31. Rifins: A second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum
32. Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses
33. Molecular aspects of severe malaria
34. Malaria research: Host-parasite interactions and new developments in chemotherapy, immunology and vaccinology
35. The malaria antigens
36. Plasmodium falciparum malaria: Evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity
37. Prognostic value of anti-Plasmodium falciparum specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria
38. Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites
39. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, West Africa)
40. Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass
41. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria
42. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: Association of high IgE levels with cerebral malaria
43. Differential immunoglobulin E and cytokine responses in BALB/c and C57B1/6 mice during repeated infections with blood-stage Plasmodium chabaudi malaria
44. IgE and tumor necrosis factor in malaria infection
45. Contrasting functions of IgG and IgE antimalarial antibodies in uncomplicated and severe Plasmodium falciparum malaria
46. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria
47. Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion
48. Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells
49. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria
50. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes
51. GM-CSF-induced priming of human neutrophils for enhanced phagocytosis and killing of asexual blood stages of Plasmodium falciparum: Synergistic effects of GM-CSF and TNF
52. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages
53. Malaria transmission and naturally acquired immunity to PfEMP-1
54. Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: Evidence for rare and prevalent variants
55. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections
56. Malaria immunity: An overview with emphasis on T cell function
57. T-cell responses to pre-erythrocytic stages of malaria - Role in protection and vaccine development against pre-erythrocytic stages
58. Common West African HLA antigens are associated with protection from severe malaria
59. Field studies of cytotoxic T lymphocytes in malaria infections: Implications for malaria vaccine development
60. The role of T cells in immunity to malaria and the pathogenesis of disease
61. T-cell control of immunity to the asexual blood stages of the malaria parasite
62. Production by activated human T cells of interleukin 4 but not interferon-γ is associated with elevated levels of serum antibodies to activating malaria antigens
63. Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: A prospective study in a malaria-endemic region of West Africa
64. Immunology of human malaria. A cellular perspective
65. Development of γδ T cells
66. High frequency of circulating γδ T cells with dominance of the Vδ1 subset in a healthy population
67. Preferential expansion of Vγ9 Vδ2 T cells following stimulation of peripheral blood lymphocytes with extracts of Plasmodium falciparum
68. Human peripheral blood γδ T cells respond to antigens of Plasmodium falciparum
69. Polyclonal expansion of peripheral γδ T cells in human Plasmodium falciparum malaria
70. Human γδ T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R
71. γδ + T cells preferentially respond to live rather than killed malaria parasites
72. Activation of γδ T cells in malaria: Interaction of cytokines and a schizont-associated Plasmodium falciparum antigen
73. The effects of interleukin-15 on human γδ T cell responses to Plasmodium falciparum in vitro
74. Direct presentation of non-peptide prenyl pyrophosphate antigens to human γδ T cells
75. Biology of γδ T cells in tuberculosis and malaria
76. Plasmodium falciparum stimuli for haman γδ T cells are related to phoshorylated antigens of mycobacteria
77. Recognition of stress induced MHC molecules by intestinal epithelial γδ T cells
78. T cell cytokines in malaria: Their role in the regulation of neutrophil and macrophage mediated killing of Plasmodium falciparum asexual blood forms
79. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism
80. Sterile protection of monkeys against malaria after administration of interleukin-12
81. Immunologic and biochemical alterations in severe falciparum malaria: Relation to neurological symptoms and outcome
82. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria
83. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria
84. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya
85. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum
86. Inflammatory processes in pathogenesis of malaria
87. Tumor-necrosis factor and other cytokines in cerebral malaria: Experimental and clinical data
88. TNF concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria
89. Anti-TNF therapy inhibits fever in cerebral malaria
90. Cytokine expression in the brain in human cerebral malaria
91. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
92. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
93. TNFα*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans
94. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
95. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria
96. Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages
97. Nitric oxide and infectious diseases
98. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression
99. A dichotomous role for nitric oxide in protection against blood stage malaria infection
100. Nitric oxide, malaria, and anemia: Inverse relationship between nitric oxide production and hemoglobin concentration in asymptomatic, malaria-exposed children
101. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria
102. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria
103. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta
104. Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A
105. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: A receptor for human placental infection
106. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties
107. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria
108. Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women
109. The Th2 cytokine environment of the placenta
110. Immunity to placental malaria. I. Elevated production of interferon-γ by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria